Syndax Pharmaceuticals SNDX
NASDAQ SNDX
$13.15 -0.10 (-0.75%)
At close: Oct 21, 2026 · 4:00 PM EDT

Syndax Pharmaceuticals (SNDX) EV to EBIT (2021 - 2022)

Updated

Syndax Pharmaceuticals' EV to EBIT came in at 632.80 for Q2 2022.

Analysis

Syndax Pharmaceuticals (SNDX) EV to EBIT (2021 - 2022) Analysis & Trends

Over the trailing twelve months to Jun 30, 2022, Syndax Pharmaceuticals reported EV to EBIT of -308.11; for FY2021, it came in at 29.12.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Syndax Pharmaceuticals 1.17 Bn -558.85 Mn 69.58 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 632.80
Mar 31, 2022 33.79
Dec 31, 2021 29.12
API Access

Syndax Pharmaceuticals EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=SNDX&period=max&api_key=YOUR_API_KEY